Basal Cell Carcinoma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Dec-2019 | List of Tables : 36 | List of Figures : 71 | No. of Pages : 170 | Report Code : FACT4366MR |

Introduction of Non-surgical Treatments to Propel BCC Treatment Market at 9% CAGR

Delay in basal cell carcinoma (BCC) treatment can lead to complications regarding the skin, muscle, and even bone damage. Hence, patients suffering from BCC are opting for non-surgical treatments such as superficial radiation therapy (SRT), since this treatment is associated with fewer complications. SRT is gaining increased popularity in the basal cell carcinoma treatment market. This is because conventional radiotherapy treatment has become impractical for dermatologists. Large obsolete machines for conventional SRT are difficult to maintain and are challenging to operate for the average community dermatologist. The basal cell carcinoma treatment market is projected for high growth with the introduction of modernized SRT. This growth is further catalyzed with healthcare providers combining SRT with Mohs surgery for the effective treatment of BCC.

SRT leads to better patient outcomes, as the treatment only affects the cancer cells, thus allowing the healthy cells to survive and rejuvenate. Healthcare companies in the basal cell carcinoma treatment market can capitalize on this highly-lucrative segment by increasing the availability of SRT in hospitals and specialty clinics. SRT can help companies expand their incremental opportunities, as it can be used for the treatment of other non-melanomas cancers such as squamous cell carcinoma.

basal cell carcinoma treatment market analysis by drug

For detailed insights on market taxonomy, request a sample copy of the report here.

Companies Experimenting with Dosing Regimens of Hedgehog Pathway Inhibitor Drugs for Treatment of BCC

Healthcare companies in the basal cell carcinoma treatment landscape are developing improved formulations of drugs to reduce the incidence of basal cell carcinoma. As such, drugs account for the second-highest revenue amongst all treatment options in the basal cell carcinoma treatment market, with a projected value of US$ 2.3 billion by the end of 2025.

Apart from surgical and other treatment options, drugs are expected to experience exponential growth in adoption during the forecast period of 2020–2025. Healthcare companies in the basal cell carcinoma treatment market are introducing hedgehog pathway inhibitors, a novel drug class for the treatment of basal cell carcinoma. Since BCC is one of the most common cancers in the U.S, companies are increasing production capacities to manufacture hedgehog pathway inhibitor drugs in this region. However, the drug is associated with adverse effects in patients, such as muscle spasms and drug-resistance. Hence, companies in the basal cell carcinoma treatment market are assessing the dosing regimens for the effective BCC treatment.

regional analysis for basal cell carcinoma treatment market by surgery

For detailed regional analysis, request a sample copy of the report here.

Radiotherapy and Emergence of CROs Trigger Market Growth

North America and Asia Pacific are anticipated to exhibit high growth potential in the basal cell carcinoma treatment market. North America alone is expected to generate a revenue of US$ 5.8 billion by 2025, and retain its dominance in the market. Increasing awareness about BCC and its improved treatment options have triggered market growth in the region. The Skin Cancer Foundation is a global organization that strives to create awareness about BCC, and aims to continue its fellowship training program to teach the right techniques of Mohs surgery to dermatologists.

Asia Pacific is projected to account for the third-highest revenue amongst all regions in the global basal cell carcinoma treatment market. The emergence of new contract research organizations that offer valuable insights on various dermatological treatments to healthcare providers is catalyzing growth in the market landscape. This trend is aiding the strengthening of the healthcare infrastructure in various countries of the Asia Pacific region.

Basal Cell Carcinoma Treatment Market – Scope of the Study

Fact.MR, in its exclusive research report on the basal cell carcinoma treatment market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the basal cell carcinoma treatment market during the forecast period (2020-2025). With the help of important insights discussed in this study, stakeholders will gain a thorough idea regarding the growth projection of the basal cell carcinoma treatment market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the basal cell carcinoma treatment market. The study also assesses the impact of each of these dynamics to estimate the size of the basal cell carcinoma treatment market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that hold potential to influence the growth of the basal cell carcinoma treatment market during the forecast period.

The global study on the basal cell carcinoma treatment market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the basal cell carcinoma treatment landscape. In addition, the analysis also discusses the threat of substitutes and new drug entrants, which provides a brief idea regarding the future growth course of the basal cell carcinoma treatment market.

The global study offers crucial information about global, regional, and local players operating in the basal cell carcinoma treatment market, along with their estimated market share, which has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players, the study also aims at educating stakeholders with the best of information regarding winning strategies, recent developments, and financials.

Basal Cell Carcinoma Treatment Market – Assessment of Key Segments

With an aim to offer granular level insights into the basal cell carcinoma treatment market, authors of the report have segmented the landscape on the basis of treatment, end user, and region. This global research report also throws light on the incremental opportunities available in the basal cell carcinoma treatment market landscape during the forecast period. Key segments of the basal cell carcinoma treatment market include:

Treatment

End User

Region

Surgery

  • Surgical Excision
  • Electrodessication & Cutterage (ED&C)
  • Mohs Surgery
  • Cryosurgery

Hospitals

North America

Drugs

  • Topical Treatment
  • Advanced Medication
  • Other

 

Specialty Clinics

Europe

Others

  • Radiation Therapy
  • Photodynamic Therapy (PDT)
  • Laser Therapy

 

Others

Asia Pacific

 

 

Middle East & Africa

 

 

Latin America

 

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the global basal cell carcinoma treatment market. This exclusive guide offers crucial information about the current trends, future scope, and government regulations for the basal cell carcinoma treatment market.

This comprehensive study also contains detailed insights of the players present in the basal cell carcinoma treatment market, which include Valeant Pharmaceuticals International, Inc., F. Hoffmann-La Roche Ltd., Sun Pharmaceuticals Ltd., Mylan N.V., and Merck & Co., Inc.

Basal Cell Carcinoma Treatment Market – Research Methodology

Research undertaken by seasoned analysts at Fact.MR consists of a systematic approach. A combination of the bottom-up and top-down approach is leveraged to estimate the size of the basal cell carcinoma treatment market. Besides this, primary and secondary research studies are carried out through credible sources to acquire crucial insights into the basal cell carcinoma treatment market. For conducting primary research, interviews and discussions were carried out with industry experts, vendors, key opinion leaders, and distributors.

Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the basal cell carcinoma treatment market. In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as company annual reports, investor presentations, and SEC-filings were studied.

Request research methodology of this report.

1 Preface 

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Basal Cell Carcinoma Treatment: Market Snapshot

    3.2. Market Share Analysis by Region, 2016

    3.3. Market Opportunity Map

4. Market Overview

    4.1. Market Overview

    4.2. Global Basal Cell Carcinoma Treatment Market: Market Indicators

    4.3. Global Basal Cell Carcinoma Treatment Market Size (US$ Mn) Forecast, 2020–2025

    4.4. Global Basal Cell Carcinoma Treatment Market: Market Outlook

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

        5.2.1. Changing Environmental Factors

        5.2.2. Stringent Regulatory Policies Assuring Better Product Quality

        5.2.3. Favorable Reimbursement Scenario

        5.2.4. Growing Disease Awareness Initiatives

        5.2.5. Rise in Geriatric Population

    5.3. Restraints

        5.3.1. Lack of Awareness in Developing Countries

        5.3.2. High Cost of Treatment 

    5.4. Opportunities

        5.4.1. Emerging Markets in Developing Countries

        5.4.2. Alternative Potential Therapies

    5.5. Key Trends

    5.6. Basal Cell Carcinoma Treatment Market: Value Chain Analysis 

    5.7. Pipeline Analysis: Basal Cell Carcinoma Market

    5.8. Key Success Factors of Top 3 Companies

    5.9. Healthcare Overview 

6. Basal Cell Carcinoma Treatment Market Analysis, by Treatment

    6.1. Introduction

    6.2. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Treatment

    6.3. Basal Cell Carcinoma Treatment Market Forecast, by Treatment

        6.3.1. Surgical

            6.3.1.1. Surgical Excision

            6.3.1.2. Electrodessication & Cutterage (ED&C)

            6.3.1.3. Moh's Surgery

            6.3.1.4. Cryosurgery

        6.3.2. Drugs

            6.3.2.1. Topical Treatment

            6.3.2.2. Advanced Medication

            6.3.2.3. Other

        6.3.3. Others

            6.3.3.1. Radiation Therapy

            6.3.3.2. Photodynamic Therapy (PDT)

            6.3.3.3. Laser Therapy

    6.4. Market Attractiveness Analysis, by Treatment

7. Basal Cell Carcinoma Treatment Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by End-user

    7.3. Basal Cell Carcinoma Treatment Market Forecast, by End-user

        7.3.1. Hospitals

        7.3.2. Specialty Clinics

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Basal Cell Carcinoma Treatment Market Analysis, by Region

    8.1. Global Basal Cell Carcinoma Treatment Market, Global Market Scenario

    8.2. Global Basal Cell Carcinoma Treatment Market Value Share Analysis, by Region

    8.3. Basal Cell Carcinoma Treatment Market Forecast, by Region

    8.4. Market Attractiveness Analysis, by Region

9. North America Basal Cell Carcinoma Treatment Market Analysis

    9.1. Regional Outlook

    9.2. Market Overview

    9.3. Market Analysis, by Treatment

        9.3.1. Market Value Share Analysis, by Treatment

        9.3.2. Market Size (US$ Mn) Forecast, by Treatment

            9.3.2.1. Surgical

                9.3.2.1.1. Surgical Excision

                9.3.2.1.2. Electrodessication & Cutterage (ED&C)

                9.3.2.1.3. Moh's Surgery

                9.3.2.1.4. Cryosurgery

            9.3.2.2. Drugs

                9.3.2.2.1. Topical Treatment

                9.3.2.2.2. Advanced Medication

                9.3.2.2.3. Other

            9.3.2.3. Others

                9.3.2.3.1. Radiation Therapy

                9.3.2.3.2. Photodynamic Therapy (PDT)

                9.3.2.3.3. Laser Therapy

    9.4. Market Analysis, by End-user

        9.4.1. Market Value Share Analysis, by End-user

        9.4.2. Market Size (US$ Mn) Forecast, by End-user

            9.4.2.1. Hospitals

            9.4.2.2. Specialty Clinics

            9.4.2.3. Others

    9.5. Market Analysis, by Country

        9.5.1. Market Value Share Analysis, by Country

        9.5.2. Market Size (US$ Mn) Forecast, by Country, 2020–2025

            9.5.2.1. U.S.

            9.5.2.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. by Country

        9.6.2. by Treatment

        9.6.3. by End-user

10. Europe Basal Cell Carcinoma Treatment Market Analysis

    10.1. Regional Outlook

    10.2. Market Overview

    10.3. Market Analysis, by Treatment

        10.3.1. Market Value Share Analysis, by Treatment

        10.3.2. Market Size (US$ Mn) Forecast, by Treatment

            10.3.2.1. Surgical

                10.3.2.1.1. Surgical Excision

                10.3.2.1.2. Electrodessication & Cutterage (ED&C)

                10.3.2.1.3. Moh's Surgery

                10.3.2.1.4. Cryosurgery

            10.3.2.2. Drugs

                10.3.2.2.1. Topical Treatment

                10.3.2.2.2. Advanced Medication

                10.3.2.2.3. Other

            10.3.2.3. Others

                10.3.2.3.1. Radiation Therapy

                10.3.2.3.2. Photodynamic Therapy (PDT)

                10.3.2.3.3. Laser Therapy

    10.4. Market Analysis, by End-user

        10.4.1. Market Value Share Analysis, by End-user

        10.4.2. Market Size (US$ Mn) Forecast, by End-user

            10.4.2.1. Hospitals

            10.4.2.2. Specialty Clinics

            10.4.2.3. Others

    10.5. Market Analysis, by Country

        10.5.1. Market Value Share Analysis, by Country

        10.5.2. Market Size (US$ Mn) Forecast, by Country, 2020–2025

            10.5.2.1. UK

            10.5.2.2. Germany

            10.5.2.3. France

            10.5.2.4. Spain

            10.5.2.5. Italy

            10.5.2.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. by Country

        10.6.2. by Treatment

        10.6.3. by End-user

11. Asia Pacific Basal Cell Carcinoma Treatment Market Analysis

    11.1. Regional Outlook

    11.2. Market Overview

    11.3. Market Analysis, by Treatment

        11.3.1. Market Value Share Analysis, by Treatment

        11.3.2. Market Size (US$ Mn) Forecast, by Treatment

            11.3.2.1. Surgical

                11.3.2.1.1. Surgical Excision

                11.3.2.1.2. Electrodessication & Cutterage (ED&C)

                11.3.2.1.3. Moh's Surgery

                11.3.2.1.4. Cryosurgery

            11.3.2.2. Drugs

                11.3.2.2.1. Topical Treatment

                11.3.2.2.2. Advanced Medication

                11.3.2.2.3. Other

            11.3.2.3. Others

                11.3.2.3.1. Radiation Therapy

                11.3.2.3.2. Photodynamic Therapy (PDT)

                11.3.2.3.3. Laser Therapy

    11.4. Market Analysis, by End-user

        11.4.1. Market Value Share Analysis, by End-user

        11.4.2. Market Size (US$ Mn) Forecast, by End-user

            11.4.2.1. Hospitals

            11.4.2.2. Specialty Clinics

            11.4.2.3. Others

    11.5. Market Analysis, by Country

        11.5.1. Market Value Share Analysis, by Country

        11.5.2. Market Size (US$ Mn) Forecast, by Country, 2020–2025

            11.5.2.1. Australia & New Zealand

            11.5.2.2. Japan

            11.5.2.3. China

            11.5.2.4. Rest of APAC

    11.6. Market Attractiveness Analysis

        11.6.1. by Country

        11.6.2. by Treatment

        11.6.3. by End-user

12. Latin America Basal Cell Carcinoma Treatment Market Analysis

    12.1. Regional Outlook

    12.2. Market Overview

    12.3. Market Analysis, by Treatment

        12.3.1. Market Value Share Analysis, by Treatment

        12.3.2. Market Size (US$ Mn) Forecast, by Treatment

            12.3.2.1. Surgical

                12.3.2.1.1. Surgical Excision

                12.3.2.1.2. Electrodessication & Cutterage (ED&C)

                12.3.2.1.3. Moh's Surgery

                12.3.2.1.4. Cryosurgery

            12.3.2.2. Drugs

                12.3.2.2.1. Topical Treatment

                12.3.2.2.2. Advanced Medication

                12.3.2.2.3. Other

            12.3.2.3. Others

                12.3.2.3.1. Radiation Therapy

                12.3.2.3.2. Photodynamic Therapy (PDT)

                12.3.2.3.3. Laser Therapy

    12.4. Market Analysis, by End-user

        12.4.1. Market Value Share Analysis, by End-user

        12.4.2. Market Size (US$ Mn) Forecast, by End-user

            12.4.2.1. Hospitals

            12.4.2.2. Specialty Clinics

            12.4.2.3. Others

    12.5. Market Analysis, by Country

        12.5.1. Market Value Share Analysis, by Country

        12.5.2. Market Size (US$ Mn) Forecast, by Country, 2020–2025

            12.5.2.1. Brazil

            12.5.2.2. Mexico

            12.5.2.3. Rest of LATAM

    12.6. Market Attractiveness Analysis

        12.6.1. by Country

        12.6.2. by Treatment

        12.6.3. by End-user

13. Middle East & Africa Basal Cell Carcinoma Treatment Market Analysis

    13.1. Regional Outlook

    13.2. Market Overview

    13.3. Market Analysis, by Treatment

        13.3.1. Market Value Share Analysis, by Treatment

        13.3.2. Market Size (US$ Mn) Forecast, by Treatment

            13.3.2.1. Surgical

                13.3.2.1.1. Surgical Excision

                13.3.2.1.2. Electrodessication & Cutterage (ED&C)

                13.3.2.1.3. Moh's Surgery

                13.3.2.1.4. Cryosurgery

            13.3.2.2. Drugs

                13.3.2.2.1. Topical Treatment

                13.3.2.2.2. Advanced Medication

                13.3.2.2.3. Other

            13.3.2.3. Others

                13.3.2.3.1. Radiation Therapy

                13.3.2.3.2. Photodynamic Therapy (PDT)

                13.3.2.3.3. Laser Therapy

    13.4. Market Analysis, by End-user

        13.4.1. Market Value Share Analysis, by End-user

        13.4.2. Market Size (US$ Mn) Forecast, by End-user

            13.4.2.1. Hospitals

            13.4.2.2. Specialty Clinics

            13.4.2.3. Others

    13.5. Market Analysis, by Country

        13.5.1. Market Value Share Analysis, by Country

        13.5.2. Market Size (US$ Mn) Forecast, by Country, 2020–2025

            13.5.2.1. South Africa

            13.5.2.2. GCC Countries

            13.5.2.3. Rest of MEA

    13.6. Market Attractiveness Analysis

        13.6.1. by Country

        13.6.2. by Treatment

        13.6.3. by End-user

14. Company Profiles

    14.1. Basal Cell Carcinoma Treatment Market Share Analysis, by Company (2016)

    14.2. Company Profiles

        14.2.1. Sun Pharmaceuticals Ltd.

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Financial Overview

            14.2.1.3. Product Portfolio

            14.2.1.4. SWOT Analysis

            14.2.1.5. Strategic Overview

        14.2.2. Valeant Pharmaceuticals International, Inc.

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Financial Overview

            14.2.2.3. Product Portfolio

            14.2.2.4. SWOT Analysis

            14.2.2.5. Strategic Overview

        14.2.3. Mylan N.V.

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Financial Overview

            14.2.3.3. Product Portfolio

            14.2.3.4. SWOT Analysis

            14.2.3.5. Strategic Overview

        14.2.4. F. Hoffmann-La Roche Ltd. 

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Financial Overview

            14.2.4.3. Product Portfolio

            14.2.4.4. SWOT Analysis

            14.2.4.5. Strategic Overview

        14.2.5. Merck & Co., Inc.

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Financial Overview

            14.2.5.3. Product Portfolio

            14.2.5.4. SWOT Analysis

            14.2.5.5. Strategic Overview

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

Basal Cell Carcinoma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025